MedTrace Logo

Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder

NCT01615679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 468

Last updated 2015-04-15

No results posted yet for this study

Summary

Non-interventional study to gain further information about the therapy progression in routine treatment of adults with attention-deficit/hyperactivity disorder (ADHD). Main focus will be on the improvement of the clinical global impression (CGI) in comparison to the outcome of randomized, controlled studies.

Conditions

  • Adult Attention-deficit/Hyperactivity Disorder

Sponsors & Collaborators

  • Medice Arzneimittel Pütter GmbH & Co KG

    lead INDUSTRY

Principal Investigators

  • Roland Fischer, Dr. · Medice Arzneimittel Pütter GmbH & Co KG

  • Michael Rösler, Prof. Dr. · Universität des Saarlandes, Institut für Gerichtliche Psychologie und Psychiatrie

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-03-31
Completion
2014-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01615679 on ClinicalTrials.gov